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Highlights 
 This is the first systematic review to explore the validity and reliability of consumer-grade 
activity trackers for recording step count and activity duration in older, community-dwelling 
adults. 
 Consumer wearables are valid in the measurement of step count and duration of physical 
activity, as confirmed by reference monitors or gold-standard validation techniques. 
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 The majority of consumer wearables overestimated step count, and to a lesser extent 
duration of physical activity.  
 Slower walking speed and impaired ambulation reduced the level of agreement between 
consumer wearables and reference devices. 
 
Abstract 
Objective: To understand the validity and reliability of consumer-grade activity trackers (consumer 
wearables) in older, community-dwelling adults. 
Methods: A systematic review of studies involving adults aged over 65 years who underwent 
physical activity monitoring with consumer wearables. A total of 7 observational studies qualified, 
identified from electronic databases: MEDLINE, EMBASE, Cochrane Library and others (2014 to 
2018). Validity was interpreted using correlation coefficients (CC) and percentage error for 
agreement between reference devices or gold-standard validation methods. Reliability was 
compared using mean differences or ranges (under- or overestimation) of step count and activity 
time.  
Results: Total sample size was 290 adults, mean age of 70.2±4.8 years and females constituting 
46.7±26.1%. The studies evaluated eight different consumer wearables used by community-dwelling 
adults with a range of co-morbidities. Daily step count for all consumer wearables correlated highly 
with validation criterion, especially the ActiGraph device: intraclass correlation coefficients (ICC) 
were 0.94 for Fitbit One, 0.94 for Zip, 0.86 for Charge HR and 0.96 for Misfit Shine. Slower walking 
pace and impaired ambulation reduced the levels of agreement. Daily step count captured by Fitbit 
Zip was on average 7117 (±5,880.6), which was overestimated by five of the eight consumer 
wearables compared with reference devices (range 167.6 to 2,690.3 steps/day). Measurement of 
activity duration was accurate compared with reference devices, yet less so than step count. 
Conclusion: In older, community-dwelling adults, consumer wearables accurately measure step 
count and activity duration, as confirmed by reference devices and validation methods. Further 
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research is required to understand how co-morbidities, gait and activity levels interact with 
monitoring in free-living environments. 
 
Keywords, older, physical activity, exercise, tracker, wearable, measure. 
 
1. Introduction 
 
Healthy ageing has evolved from simply a desire to increase life expectancy, to more aspirational 
aims of avoiding disease, preserving physical functioning and allowing an independent engagement 
with life. Compelling evidence from meta-analyses and Cochrane reviews demonstrate the benefits 
of exercise, especially when physical activity (PA) is planned, structured and underpinned by the goal 
to improve or maintain physical fitness, performance and health for elderly people [1]. Exercise 
benefits for older people not only include prevention and treatment of increasingly prevalent 
chronic conditions, such as cardiovascular disease, but often more importantly, improvements in 
health-related quality of life [2]. The World Health Organisation [3] recommends a minimum average 
daily activity of 30 minutes at moderate-intensity, which can be achieved through walking (steps) 
and walking rapidly or uphill (steps/time). Free-living PA can be defined as a person's everyday 
physical activity in their usual environment, and for older, community-dwelling adults it is free-living 
PA which is crucial. The aims of PA in older people are to reduce sedentary behaviour, increase 
autonomy in daily activities and sustain long-term exercise goals, and as such these objectives are 
recommended to be achieved in older people’s normal surroundings [4]. 
 
Contemporary technology provides an unprecedented opportunity for the use of consumer-grade 
activity trackers (consumer wearables) to both understand, investigate and promote sustainable PA 
in older people. The measurement of PA is essential to all of these aims. The mainstay of 
measurement in older people has been self-report, and less often through the use of research-grade 
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activity trackers. Self-report has inherent limitations, including the need to monitor duration and 
type of PA is being undertaken, as well as the capacity to recall specific aspects [5]. Often both these 
necessary attributes are flawed, leading to overestimation. Furthermore, self-report questionnaires 
have been criticised for the tendency to be age-or disease biased, excluding common elements of 
regular physical activity (e.g. personal care or domestic tasks), both potentially creating restrictions 
in accurate responses from older people. In contrast, research-grade motion sensors, which monitor 
activity such as pedometers, actometers and accelerometers, circumvent these issues by direct 
tracking [6].  Whilst these measurement devices are validated, they are often cumbersome and 
difficult to apply, therefore less useful in long-term monitoring of everyday PA in older community-
dwelling adults, for either research requirements or personal motivation. Consequently, within the 
array of trackers, it is the consumer-grade physical activity trackers (e.g. FitbitTM, PolarTM, GarminTM, 
Apple Watch SportTM), which may become the preferred self-monitoring, measurement option. 
Many studies to date have sought to validate the growing range of consumer-grade activity trackers, 
in both ‘controlled’ laboratory and ‘free-living’ environments [7,8], and with healthy and disease-
specific cohorts. Evenson et al (2015) [9] published the most recent systematic review on the validity 
of consumer wearables to monitor PA, and reported at the time of the search in 2014 only one study 
[4] had an older adult sample. Therefore, this systematic review aims to provide an update on prior 
evidence, with a specific focus on studies reporting the validity and reliability of consumer-grade 
activity trackers in older, community-dwelling adults. 
 
2. Methods 
2.1 Search Strategy 
 
The review was guided by Preferred Reporting Items for Systematic Review and Meta-Analyses 
(PRISMA) [10], with inclusion criteria and methods of analyses decided in advance. We performed a 
systematic search of three electronic databases MEDLINE, CINAHL and COCHRANE Central Register 
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of Controlled Clinical Trials, from November 2014 to January 2018. For the purpose of this review, 
the keywords searched included ‘older’, ‘physical activity’, ‘exercise’, ‘steps’, ‘tracker’, ‘wearable’, 
‘consumer-grade’ and ‘measure’ amongst others. Additional manual searches of reference lists from 
eligible papers, related trial bibliographies, conference abstracts and Google Scholar (Figure 1) were 
undertaken. The eligibility of articles was independently assessed by two authors (NS, RG), and a 
third author (MA) made the decision when uncertainty occurred. Studies fulfilling the following 
criteria were included: (1) samples of community-dwelling adults (2) age >65 years, or having a 
sample mean age of >65 years, (3) measurement of step count with or without activity duration 
(time), using at least one consumer-grade activity tracker (wearable) (excluding pedometer only 
devices) and (4) the monitored period was in a ‘free-living’ or ‘controlled’ environment. Studies were 
excluded if the full-text was not available or published in a language other than English. 
 
2.2 Data Extraction and Quality Assessment 
 
Data was collected from eligible studies including, but not limited to, first author, publication year, 
location (country), sample size, age, proportion of female, chronic medical condition(s), consumer-
grade tracker used, placement, step count, activity duration (minutes or hours), monitoring period, 
reference measure, validity and reliability outcomes. The Critical Appraisal Skills Programme CASP 
(Cohort Study) Checklist was used to assess quality. On assessment, 75% of the studies met a 
minimum 80% of the evaluation criteria and therefore no paper was excluded on the basis of this 
quality assessment. 
 
2.3 Data Analysis 
 
For any extracted information that was missing from the publication, we made an attempt to 
contact at least one author to obtain the information. We tabulated our data, highlighting study 
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characteristics, consumer-grade activity tracker specifics, validity measures and comparative 
reliability of devices. Validity is reported on the basis of correlation coefficients (CC) and percentage 
error for agreement between devices or gold standard direct observation methodology (e.g. visual 
count). Reliability is reported as the mean differences or range (under or overestimation) of step 
count and activity duration versus similar validity comparators. In addition, we report activity 
monitor placement and the potential effects this had upon reliability of both devices. 
  
3. Results 
3.1 General characteristics of studies 
 
The initial search identified 976 abstracts published since 2014, of which 956 were excluded; 20 
papers had full-text assessment (Figure 1). Further examination excluded 13 studies and the 
remaining 7 studies were included in the review. The total sample includes 290 participants with a 
mean age of 70.2±4.8 years and females constitute 46.7±26.1% (Table 1). Studies were performed in 
Europe [14,16], Australia [11,13], UK [17], US [15] and Canada [12]. Of the samples, one recruited 
participants during hospitalisation yet the primary monitoring period was measured in a free-living 
environment [16], the remainder were community-dwelling adults. Two studies [13,16] had samples 
diagnosed with coronary heart disease (CHD) and one [14] had sample of chronic obstructive 
pulmonary disease (COPD) patients. The remainder of the studies did not have specific disease-
based criteria.      
 
3.2 Activity trackers and monitoring trends 
 
In total, eight different consumer-grade activity trackers were included in this review (Table 2), 
including Fitbits OneTM, ZipTM, FlexTM and Charge HRTM,  Jawbone UPTM, Misfit ShineTM, Omron HJ-
112TM and Polar A300TM. Devices were used in both combination [11,15,17] and alone [12,13,14,16]. 
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Validity was assessed primarily against research-grade devices including ActiGraphTM, Bodymedia 
SensewearTM, Shimmer3TM and NL2000iTM, however two studies [11,12] also used direct visual count 
as a comparator. Consumer-grade activity trackers were worn on the waist (50%), wrist (40%) and 
ankle (10%). Only two studies reported activity as overall duration [13,14], though seven of the eight 
consumer-grade trackers had the capability to do so. Five studies [11,13,14,16,17] required 
participants to monitor activity in their own free-living environments for a time period ranging from 
3 to 28.2 days from placement. In two studies activity was monitored in controlled settings using 
pre-determined walking tracks and regulated gym conditions [12,15]. 
 
3.3 Validity of consumer-grade activity trackers (step count and activity time) 
 
There was a high correlation in daily step count between the eight consumer-grade activity trackers 
and the reference research-grade trackers or study comparator (Table 3), over a monitoring period > 
24 hours in a free-living environment, in all but one study [16]. Validity was high versus ActiGraphTM, 
the mostly commonly used reference device, with intraclass correlation coefficients (ICC) for Fitbit 
One TM (0.94), Zip TM (0.94), Charge HR TM (0.86) and Misfit ShineTM (0.96). One study [12] that 
evaluated monitoring accuracy within controlled environments, reported that during speed trials 
when compared to a visual count, the percentage error varied depended on placement of the Fitbit 
One TM. At ankle level, agreement was <10% at speeds of 0.4–0.9 m/s and at waist <10% for only the 
2 fastest speeds 0.8 and 0.9 m/s [12]. The conclusion was that Fitbit One TM accurately captures steps 
at slow speeds when placed at the ankle. Another study [15] compared the Stepwatch TM with four 
consumer-grade activity trackers worn at the same time, and reported that three (Omron HJ-112 TM, 
Fitbit One TM, and Jawbone UP TM) were accurate at measuring steps, in both non-impaired and 
impaired ambulation, older adults. Daily activity duration was also accurately captured by consumer-
grade devices compared to reference trackers, although at a lower correlation than for step counts 
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(Fitbit Flex TM vs ActiGraph TM MVPA (r=0.74 Pearson correlation coefficient) [13] and Polar A300TM vs 
Bodymedia Sensewear TM (r=0.25 ICC) [14]. 
 
3.4 Reliability of consumer-grade activity trackers (step count and activity time) 
 
Daily step count was reported to be overestimated in the majority of cases, and regardless of device 
location (Table 4). Participants (mean age 67±10.03) monitored over a four-week period with a 
consumer-grade activity tracker walked an average 7,117 steps per day (±5,880.6) [16]. This is 
comparable to average daily steps captured by the ActiGraph TM (research-grade) device in 
community-dwelling seniors, enrolled without a pre-requisite clinical condition (7,503.7±3,526.3 
steps per day), over a seven-day monitoring period. Compared to research-grade monitors, four 
studies [11,13,14,17] reported an overestimation in daily step counts in five of the eight consumer-
grade activity trackers (Fitbit OneTM, Fitbit ZipTM, Fitbit FlexTM, Fitbit Charge HRTM and Polar A300TM), 
with discrepancies ranging from 167.6 to 2,690.3 [17] steps per day. In contrast, two devices 
underestimated daily steps taken, Fitbit Zip TM (waist by 2402.7) and Misfit Shine TM (waist by 633.2) 
versus research-grade devices [16,17]. Lastly, compared to research-grade monitors, physical activity 
duration was overestimated [13] by the Fitbit Flex TM (average 10 min/day) and highly variable when 
measured with the Polar A300 TM device [14]. 
 
4. Discussion 
 
Our paper which includes an additional seven studies to the most recent systematic review [9], 
provides further evidence contributing to the use of consumer wearables for the measurement of 
physical activity. To our knowledge this is the first systematic review to explore the validity and 
reliability of consumer-grade activity trackers for measuring step count and duration of PA in older, 
community-dwelling adults. Consumer wearables proved valid in the measurement of step count 
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and duration of PA when compared to research-grade activity trackers or visual (step-count) 
reference techniques. Slower walking speed and impaired ambulation reduced agreement. Most 
consumer-grade activity trackers overestimated step count, and to a lesser extent duration of PA. 
Furthermore, in older people who have very slow walking speeds, careful consideration needs to be 
given to tracker selection. These are important finding given the growth in the use of consumer-
grade activity trackers to monitor and improve physical activity in health-care research and for 
independent use by consumers.  
 
4.1 Validity and reliability of consumer-grade activity trackers in older adults 
 
Tracking of free-living activity allows shared decision-making amongst patients and healthcare 
practitioners, when evaluating intervention need versus expected quality of life gains. 
With the majority of consumer-grade activity trackers evaluated effectively capturing PA in older 
adults, future use may serve several research and interventional purposes requiring this accurate 
measurement. Such devices may be substituted for research-grade devices when evaluating 
interventions, prescribing PA and for self-monitoring by older people to manage their own activity 
levels. Physical functioning is imperative to allow seniors to engage fully and independently with 
their environment, especially as their complex care demands change. As such, consumer wearables 
may have particular benefit for older adults [18]. 
 
As people age, many walk at a slower pace, experience uneven gait patterns and often require 
walking aids. It was at these reduced walking speeds or lower activity levels, that several studies 
[12,13,16] in this review reported greater percentage error or data acquisition difficulties, compared 
to validation devices and methods. Unfortunately, many individuals with chronic diseases, often 
experience common disease symptoms, such as breathlessness or fatigue (i.e. COPD or heart failure 
patients) and thus are prone to experience daily physical limitations [19]. In terms of device 
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placement, again there was disparity across trackers. For step count, compared to the wrist location, 
waist positioning appears to have less misrepresentation [16,17]. Whereas for COPD patients [14], 
activity duration monitoring varied significantly between the wrist-worn consumer wearable and the 
upper arm-worn validation monitor, potentially highlighting the sensitivity of the device 
components. Regardless of the variability, continuous wearing of both consumer or research-grade 
activity trackers, at the same location, provided the most accurate step count and activity duration 
results. 
 
Nonetheless, it may be these individual level variables that may pose the greatest challenges ahead. 
For instance, to date consumer wearables have been driven by the commercial development of 
fitness trackers, meaning that market guiding forces may limit capacity to influence development for 
use amongst older people [20]. Many consumer wearable algorithms are limited to recommended 
daily step counts or activity levels for that of healthy adults [21], potentially explaining the several 
measurement discrepancies observed in this review. In addition, as the use of consumer wearables 
grows, the complicated challenge of personal data management and security will become more 
apparent for patients and healthcare providers alike, an important yet unresolved matter. 
Manufacturers will need to address these issues which underpin the expansion of consumer 
wearable populations.  
 
Despite high accuracy of consumer-grade activity trackers compared to reference devices, reliability, 
was highly variable across devices in relation to agreement of steps taken per day. If we accept that 
the average daily step count for a community-dwelling older adult is around 7,500 steps/day [17], 
over-or underrepresentation varied by as much as 30% in two separate studies [16,17] between 
consumer and research-grade devices. Such variation means that the results from this study are 
difficult to apply to the wider, community-dwelling older adult population. Yet, it is important to 
acknowledge the physical activity data obtained by these consumer wearables was objective, and 
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recent studies have shown on average only 20% of adults aged 65-74 achieve 30mins of moderate-
intensity activity at least 5 days per week [22]. Therefore, such devices may have strong potential for 
older people to understand their own physical capabilities and increase self-efficacy towards 
personal and health-related goal achievement.  
 
4.2 Older adults, comorbidities and physical activity 
 
One of the important strategies to reduce aging-related morbidity is to increase physical activity 
among older people (Bauman et al. 2016) [23]. It was therefore encouraging to see that the overall 
mean age (70.2±4.8) of the sample in this review was sufficiently reflective of the aging population. 
Also, three included studies [13,14,16] deliberately enrolled participants with chronic illnesses 
(cardiac and respiratory). This is important as it is within these groups of older adults that the 
greatest gains can be made from improved physical activity [24]. Yet despite the increasing number 
of studies on older adults in this review compared to the last [9], the overall sample size was less 
than half, highlighting a gap in research being undertaken in this field for older adults. This 
underrepresentation means that current guidelines are often unable to provide comprehensive 
evidence-based information on the treatment of many chronic conditions [25].  
 
5. Limitations 
 
This review has several limitations. The literature on consumer-grade activity trackers is rapidly 
growing and it is therefore possible that studies were missed despite our best endeavors. Also, most 
studies had small samples and few had sample size calculations. The participants included in this 
review also represent a range of medical conditions, from acute clinical events to multiple chronic, 
long-term illnesses. How these different variables impact directly on step counts and physical 
activity time is not yet possible to predict. Several included studies reported issues with missing or 
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uninterpretable data across comparator devices and explanations from study investigators were not 
consistent, including altered positioning, low-intensity activity, loss of device and set-up error. 
Importantly, the commercial imperative to improve updated marketable brands of wearable 
devices, means that several of the devices reported may no longer be in production and more 
recently launched devices may become redundant before testing is complete. Despite the 
limitations, this review is needed because of the increasing challenge for healthcare researchers to 
understand and measure physical activity across the rising number of older adults in their 
community-dwelling environments. 
 
6. Conclusion 
 
This systematic review included seven studies assessing validity and reliability of consumer-grade 
activity trackers for measuring physical activity through step counts and activity time in older, 
community-dwelling adults. Overall, the consumer-grade activity trackers were highly accurate for 
measuring average daily step count, and to a lesser extent, actual activity duration compared to 
research-grade reference devices. The review also highlighted issues that need to be addressed 
should the use consumer-grade activity trackers continue to grow, especially in relation to slow 
walking speeds, device positioning and gait. Nonetheless, this review provides supporting evidence 
and a more nuanced understanding for the use of consumer-grade activity trackers in the 
assessment of functional capacity in older adults.   
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Fig 1. Search Strategy 
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Table 1. Study Characteristics 
 
First author, 
year, country 
Sample 
size (n) 
Mean 
age (yrs), 
± SD 
Female 
(%) 
Consumer-
grade activity 
tracker(s) 
Monitoring 
setting 
Monitoring 
period (days) 
Inclusion criteria Medical 
condition(s) 
         
Paul, S. S. et al 
(2015), 
Australia [11] 
32 67.7±5.7 63.0 Fitbit One 
Fitbit Zip 
free-living  7 Participants were 1) aged 60+ years, 2) living at 
home, 3) regular (weekly) users of the internet via 
a computer or tablet device and  
4) regular (at least once/week) out of home activity 
without physical assistance from another person. 
 
41% reported 1-2 
comorbidities              
(diagnoses not 
reported) 
Simpson, L. A. 
et al. (2015), 
Canada [12] 
42 73.0±6.9 74.0 Fitbit One  controlled <1 Participants were 1) aged 65+ years and 2) able to 
walk independently for at least 30 m with/without 
an assistive device. 
26% reported 
diagnosed medical 
conditions                  
(most often: high 
blood pressure, 
diabetes, and 
thyroid disorders) 
 
Alharbi, M. et 
al. (2016), 
Australia [13] 
48 65.6±6.9 47.9 Fitbit Flex free-living  4 Participants were 1) diagnosed CHD or family 2) 
completed phase II cardiac rehabilitation; 3) 
engaged in regular physical activity of 30 
minutes/day; 4)  able to participate for the full 
four-day study and 5) able to apply and wear both 
devices simultaneously. 
 
 
CHD 
Boeselt, T. et 
al. (2016), 
Germany [14] 
20 66.4±7.4 15.0 Polar A300 free-living  3 Participants were 1) were aged between 40 to 90 
years, 2) diagnosed with COPD stage I to IV and 
3) able to walk.  
 
 
 
 
 COPD 
 
Floegel, T. A. 
et al. (2017), 
US [15] 
99 78.9±8.6 71.0 Fitbit One, 
Fitbit Flex, 
Omron HJ-
controlled <1 Participants were 1) aged 62+ years, 2) met the 
health conditions on modified Physical Activity 
Readiness Questionnaire-Revised including stable 
not reported 
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112, 
Jawbone UP 
blood pressure for 3 months, no chest pain with 
activity or joint problems limiting physical activity, 
3) able to walk 100 m without stopping 
with/without an assistive device and 4) willing to 
wear all activity monitors. 
 
Thorup, C. B. 
et al (2017), 
Denmark [16] 
24* 67±10.03 8.3 Fitbit Zip controlled 
and free-
living  
1 (post-
surgery) and 
mean 28.2 
(range 26–31) 
Participants were 1) age ≥18 years and 2) 
hospitalised with acute coronary syndrome, heart 
failure (ejection fraction <40%), coronary artery 
bypass grafting or valve surgery.  
 
CHD and valvular 
heart disease  
Farina, N. et al 
(2018), UK 
[17] 
25 72.5±4.9 48.0 Misfit Shine, 
Fitbit Charge 
HR 
 
free-living  7 Participants were 1) aged 65-84 years, 2) 
community-dwelling and 3) independently 
ambulatory (walking aids excluded). 
Charlson co-
morbidity 11.7 
score 
* older participants (not younger healthy controls), SD = standard deviation *coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD) 
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Table 2. Consumer-grade activity trackers device characteristics 
 
Tracker Selected Measurement Placement Size (cm) Weight (g) Cost AUD ($) 
      
Fitbit One Steps, distance, calories, active 
minutes, sleep, altimeter 
Waist, pocket, 
bra 
 
4.8(h) × 1.9(w) × 1.0(d) 9 129.95 
Fitbit Charge 
HR 
Steps, distance, calories, active 
minutes, sleep  
 
Wrist Large: 16.1–19.4(c) × 2.1(w)                      
Extra Large: 19.4–23.0(c) × 2.1(w) 
23 249.95 
Fitbit Flex Steps, distance, calories, active 
minutes, sleep, altimeter, heart rate 
 
Wrist Small: 14.0–17.6(c) × 1.4(w)                                                                                            
Large: 16.1–20.9(c) × 1.4(w) 
13                             
15 
94.00
Fibit Zip Steps, distance, calories, active minutes 
 
Waist, pocket, 
bra 
3.6(h) × 2.9(w) × 1.0(d) 8 79.95 
Jawbone UP Steps, distance (app), calories, sleep  Wrist Small: 14.0–15.5                                                            
Medium: 15.5–18.0                                                           
Large: 18.0–20.0  
              
19           
21                        
23 
Discontinued 
December 2011.  
Misfit Shine Steps, distance, calories, active 
minutes, sleep  
 
Wrist, waist, 
necklace, bra 
2.8(h) x 2.8(w) x 0.3(d)  9 89.95 
Omron HJ-
112 
Steps, distance, calories, active minutes  
 
Waist 1.5(h) x 5.3(w) x 3.6(d) 82 110.72 
 
!
AC
CE
PT
ED
 M
AN
US
CR
IPT
21 
 
Table 3. Validity Outcomes 
 
First author, 
year, 
location 
Criterion 
measure(s) 
Consumer-
grade activity 
tracker(s) 
 
Consumer-grade 
activity tracker(s) 
placement 
 
Objective 
measures 
Validity 
analysis 
 
Outcomes 
      
 
Paul, S. S. et 
al (2015), 
Australia 
[11] 
ActiGraph & 
visual step count 
(2MWT) 
 
Fitbit One, 
Fitbit Zip 
 
Waist 
 
steps 
 
Intraclass 
correlation 
coefficients 
(ICC)                                       
 
Good agreement between Fitbit & ActiGraph (ICC2,1=0.66, 
95% CI 0.41 to 0.82). Excellent agreement between Fitbit & 
ActiGraph in average steps/day over 7 days (ICC2,1=0.94, 95% 
CI 0.88 to 0.97). Excellent agreement between Fitbit & visually 
counted steps (intraclass correlation coefficient (ICC2,1) =0.88, 
95% CI 0.76 to 0.94) on 2MWT. 
 
     Percentage 
Error 
 
Percentage agreement greatest for Fitbit steps vs visual count 
(mean 0%, SD 4%) and least for Fitbit average steps/day vs 
ActiGraph (mean 13%, SD 25%) 
 
Simpson, L. 
A. et al. 
(2015), 
Canada [12] 
visual step count 
(video 
recording) 
 
Fitbit One 
 
waist, ankle 
 
steps 
 
Percentage 
Error 
 
Percentage error of Fitbit ankle < 10% at speeds of 0.4–0.9 m/s; 
for Fitbit waist percentage error  < 10% at only the 2 fastest 
speeds (0.8 and 0.9 m/s) 
 
     Mean 
differences  
 
Fitbit ankle did not record zero steps at any speed. Fitbit waist 
recorded 0 steps for numerous participants at speeds of 0.3–0.5 
m/s.  
 
     Limits of 
agreement 
 
Limits of agreement for Fitbit – Ankle narrower than limits of 
agreement for Fitbit –Waist at all speeds. 
 
Alharbi, M. 
et al. (2016), 
Australia 
[13] 
ActiGraph 
 
Fitbit Flex 
 
wrist 
 
steps, 
MVPA 
 
Pearson 
correlation 
 
 
Significant correlation Fitbit Flex vs ActiGraph in males, 
females, total participants and cardiac patients for step counts (r 
1⁄4.96; r 1⁄4.95; r 1⁄4.95; r 1⁄4.95). Less for MVPA (r 1⁄4.81; r 
1⁄4.65, r 1⁄4.74; r 1⁄4.71) 
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     Absolute 
differences 
 
Fitbit Flex over-estimated step counts in females (556 
steps/day), males (1462 steps/day) and total participants (1038 
steps/day). MVPA similar in females (4 min/day), males (15 
min/day) and total participants (10 min/day) 
 
     Sensitivity, 
specificity, PPV 
and AUC 
 
Fitbit Flex high sensitivity (100% accuracy) for identifying 
participants achieving PA guidelines of 7000 and 10,000 
steps/day cut-off points and 150min/week cut-off points. 
Specificity and PPV of Fitbit-Flex for these cut-off points varied 
(0.83-0.57 and 0.67 respectively). Fitbit Flex high accuracy and 
specificity for participants who failed to achieve the cut-off 
values above but moderate specificity and high accuracy for 
participants who failed to achieve 7000 steps/day. 
 
Boeselt, T. et 
al. (2016), 
Germany 
[14] 
Bodymedia 
Sensewear 
(SWA) 
 
Polar A300 
 
wrist 
 
steps, 
calories, 
daily activity 
time (hrs) 
and METS 
 
Intraclass 
correlation 
coefficients 
(ICC) 
 
High correlations for both devices for sensed step count (r = 
0.96; p < 0.01) and calories burned (r = 0.74; p < 0.01), lower 
correlation to daily activity (r = 0.25; p < 0.01)  
 
     Limits of 
agreement 
 
3 day data analysis showed 90% of steps (95% CI -4223 to 
1887), 100% of calories (95% CI -2798 to 1887), 90% of daily 
activity data (95% CI -12.32, 4065) and 95% of the MET (95% 
CI -3.11 to 2.75) within limits of agreement 
 
Floegel, T. 
A. et al. 
(2017), US 
[15] 
StepWatch 
 
Fitbit One, 
Fitbit Flex, 
Omron HJ-
112, Jawbone 
UP 
 
wrist, waist 
 
steps 
 
Intraclass 
correlation 
coefficients 
(ICC) 
 
Non-impaired adults’ steps underestimated by 4.4% StepWatch 
(ICC = 0.87), 2.6% Fitbit One (ICC = 0.80), 4.5% Omron HJ-
112 (ICC = 0.72), 26.9% Fitbit Flex (ICC = 0.15), and 2.9% 
Jawbone UP (ICC = 0.55). Impaired adults’ steps 
underestimated by 3.5% for StepWatch (ICC = 0.91), 1.7% 
Fitbit One (ICC = 0.96), 3.2% Omron HJ-112 (ICC = 0.89), 
16.3% Fitbit Flex (ICC = 0.25), and 8.4% Jawbone UP (ICC = 
0.50).  
 
Cane and walker-user steps underestimated by StepWatch by 
1.8% (ICC = 0.98) and 1.3% (ICC = 0.99), respectively, all 
other monitors underestimated steps by >11.5% (ICCs < 0.05). 
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     Percentage 
Error 
 
Similar across devices, suggesting 
the direction of error (underestimation) consistent within each 
and across all devices. 
 
     Limits of 
agreement 
 
Wide limits of agreement with larger scatter observed in cane-
and walker-user groups for Fitbit One, Omron, Fitbit Flex, and 
Jawbone UP. Significant variation observed in Omron, Fitbit 
Flex, and Jawbone UP for cane-users.  
 
Thorup, C. 
B. et al 
(2017), 
Denmark 
[16] 
Shimmer3 
 
Fitbit Zip 
 
waist 
 
steps  
 
Intraclass 
correlation 
coefficients 
(ICC) 
 
Hospitalised patients 24-hour showed relative error of 
−47.15±24.11 (interclass correlation coefficient (ICC): 0.60), 
and at home, relative error −27.51±28.78 (ICC: 0.87) 
 
     Percentage 
Error 
 
Neither 24-hour test had < expected 20% error. During periods 
of evident walking in 24 hour test, Zip average relative error of 
<3% at 3.6 km/hour and higher speeds. 
 
Farina, N. et 
al (2018), 
UK [17] 
Actigraph and 
NL2000i  
 
Misfit Shine, 
Fitbit Charge 
HR  
 
wrist, waist 
 
steps  
 
Intraclass 
correlation 
coefficients 
(ICC) 
 
Two reference devices (ActiGraph and NL2000I) had near 
perfect agreement (ICC = 0.96, 95% CI: 0.89 to 0.98). All 
consumer-level activity monitors positively correlated with 
reference devices (p < .001).  Waist-worn Misfit Shine displayed 
highest agreement amongst devices (ICC = 0.96, 95% 0.91 to 
0.99). 
 
     Percentage 
Error 
 
Misfit Shine (waist) underestimated steps/day vs NL2000i (rs = 
0.90 p<0.001) and overestimated vs ActiGraph device (rs = 0.96 
p <0.001). Misfit Shine (wrist) underestimated steps/day 
compared to both reference devices (NL2000i rs = 0.89 and 
ActiGraph rs = 0.91 p < 0.001). Fitbit Charge HR (wrist) 
substantially overestimated step count vs both ActiGraph and 
NL2000i (NL2000i rs = 0.83 and ActiGraph rs = 0.84 p < 
0.001). 
 
 
 
     Limits of 
agreement 
Misfit Shine (waist) near perfect agreement vs ActiGraph and 
NL2000i. Compared to ActiGraph and NL2000i, Misfit Shine 
(Wrist) had good agreement (wide CIs), limits of agreement 
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moderately wide. Fitbit Charge HR (wrist) had very wide limits 
of agreement against ActiGraph and NL2000i. 
 
MVPA = mean vigorous physical activity, 2MWT = two-minute walk test, CI = confidence interval 
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Table 4. Reliability Outcomes 
 
First author, year, 
location 
Consumer-
grade 
activity 
tracker(s) 
Comparison 
research 
grade 
tracker(s) 
Sample 
size (n) 
Study 
Measures 
Placement of 
the consumer-
grade activity 
tracker 
Average daily step 
count recorded by 
consumer-grade 
tracker (mean, SD) 
Interdevice daily step count variability                        
(consumer vs research-grade tracker) 
        
Paul, S. S. et al 
(2015), Australia 
[11] 
 
Fitbit One, 
Fitbit Zip 
 
ActiGraph 32 steps waist NR Overestimate 716.7 steps/day                            
Simpson, L. A. et 
al. (2015), Canada 
[12] 
 
Fitbit One  ND 42 steps  waist, ankle N/A NM 
Alharbi, M. et al. 
(2016), Australia 
[13] 
 
Fitbit Flex ActiGraph 48 steps wrist NR Overestimate 1038 steps/day 
Boeselt, T. et al. 
(2016), Germany 
[14]  
 
Polar A300 Bodymedia 
Sensewear 
20 steps 
 
 
wrist NR Overestimate 183 - 596 (range) steps/day 
Floegel, T. A. et al. 
(2017), US [15] 
Fitbit One, 
Fitbit Flex, 
Omron HJ-
112, 
Jawbone 
UP 
ActiGraph 99 steps waist (Fitbit 
One, Omron 
HJ-112) and 
wrist (Fitbit 
Flex and 
Jawbone UP) 
N/A NM 
Thorup, C. B. et al 
(2017), Denmark 
[16] 
 
Fitbit Zip Shimmer3 24* steps  waist   7117±5880.6 Underestimate of 2402.7 steps/day                
Farina, N. et al 
(2018), UK [17] 
Misfit 
Shine, 
Fitbit 
Charge HR  
ActiGraph 
and NL2000i 
25 steps waist (Misfit 
Shine) and 
wrist (Fitbit 
Charge HR) 
NR  
(ActiGraph 
7503.7±3526.3) 
Misfit Shine (waist) overestimated 167.6 (MD) 
steps/ day vs ActiGraph, and underestimated by 
633.2 (MD) steps / day vs NL2000i. Misfit Shine 
(wrist) underestimated 10.1 (MD) steps/day vs 
ActiGraph and by 899.7 (MD) vs NL2000i.  
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Fitbit Charge HR (wrist) overestimated 2690.3 
steps / day vs ActiGraph and 1721.6 vs NL2000i 
respectively. 
 
 
* older participants (not younger healthy controls), MVPA = mean vigorous physical activity, NM = not measured, N/A = not applicable, NR = not reported, MD = mean 
difference 
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